Literature DB >> 22385120

Cocaine esterase-cocaine binding process and the free energy profiles by molecular dynamics and potential of mean force simulations.

Xiaoqin Huang1, Xinyun Zhao, Fang Zheng, Chang-Guo Zhan.   

Abstract

The combined molecular dynamics (MD) and potential of mean force (PMF) simulations have been performed to determine the free energy profiles for the binding process of (-)-cocaine interacting with wild-type cocaine esterase (CocE) and its mutants (T172R/G173Q and L119A/L169K/G173Q). According to the MD simulations, the general protein-(-)-cocaine binding mode is not affected by the mutations; e.g.. the benzoyl group of (-)-cocaine is always bound in a subsite composed of aromatic residues W151, W166, F261, and F408 and hydrophobic residue L407, while the carbonyl oxygen on the benzoyl group of (-)-cocaine is hydrogen-bonded with the oxyanion-hole residues Y44 and Y118. According to the PMF-calculated free energy profiles for the binding process, the binding free energies for (-)-cocaine with the wild-type, T172R/G173Q, and L119A/L169K/G173Q CocEs are predicted to be -6.4, -6.2, and -5.0 kcal/mol, respectively. The computational predictions are supported by experimental kinetic data, as the calculated binding free energies are in good agreement with the experimentally derived binding free energies, i.e., -7.2, -6.7, and -4.8 kcal/mol for the wild-type, T172R/G173Q, and L119A/L169K/G173Q, respectively. The reasonable agreement between the computational and experimental data suggests that the PMF simulations may be used as a valuable tool in new CocE mutant design that aims to decrease the Michaelis-Menten constant of the enzyme for (-)-cocaine.
© 2012 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22385120      PMCID: PMC3305836          DOI: 10.1021/jp2111605

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  32 in total

1.  Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.

Authors:  Rong Chen; Michael R Tilley; Hua Wei; Fuwen Zhou; Fu-Ming Zhou; San Ching; Ning Quan; Robert L Stephens; Erik R Hill; Timothy Nottoli; Dawn D Han; Howard H Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

2.  Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats.

Authors:  Gregory T Collins; Remy L Brim; Diwahar Narasimhan; Mei-Chuan Ko; Roger K Sunahara; Chang-Guo Zhan; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2009-08-26       Impact factor: 4.030

3.  Reaction mechanism for cocaine esterase-catalyzed hydrolyses of (+)- and (-)-cocaine: unexpected common rate-determining step.

Authors:  Junjun Liu; Xinyun Zhao; Wenchao Yang; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2011-04-12       Impact factor: 2.991

4.  Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase.

Authors:  Ziva D Cooper; Diwahar Narasimhan; Roger K Sunahara; Pawel Mierzejewski; Emily M Jutkiewicz; Nicholas A Larsen; Ian A Wilson; Donald W Landry; James H Woods
Journal:  Mol Pharmacol       Date:  2006-09-12       Impact factor: 4.436

Review 5.  Monoamine transporter pharmacology and mutant mice.

Authors:  Raul R Gainetdinov; Tatyana D Sotnikova; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2002-08       Impact factor: 14.819

Review 6.  Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy.

Authors:  D A Gorelick
Journal:  Drug Alcohol Depend       Date:  1997-12-15       Impact factor: 4.492

7.  Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase.

Authors:  Chang-Guo Zhan; Fang Zheng; Donald W Landry
Journal:  J Am Chem Soc       Date:  2003-03-05       Impact factor: 15.419

8.  Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity.

Authors:  Daquan Gao; Diwahar L Narasimhan; Joanne Macdonald; Remy Brim; Mei-Chuan Ko; Donald W Landry; James H Woods; Roger K Sunahara; Chang-Guo Zhan
Journal:  Mol Pharmacol       Date:  2008-11-05       Impact factor: 4.436

9.  A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality.

Authors:  Emily M Jutkiewicz; Michelle G Baladi; Ziva D Cooper; Diwahar Narasimhan; Roger K Sunahara; James H Woods
Journal:  Ann Emerg Med       Date:  2008-11-14       Impact factor: 5.721

10.  Free-energy perturbation simulation on transition states and redesign of butyrylcholinesterase.

Authors:  Wenchao Yang; Yongmei Pan; Fang Zheng; Hoon Cho; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  Biophys J       Date:  2009-03-04       Impact factor: 4.033

View more
  5 in total

1.  Free energy profiles of cocaine esterase-cocaine binding process by molecular dynamics and potential of mean force simulations.

Authors:  Yuxin Zhang; Xiaoqin Huang; Keli Han; Fang Zheng; Chang-Guo Zhan
Journal:  Chem Biol Interact       Date:  2016-05-06       Impact factor: 5.192

2.  Binding structures and energies of the human neonatal Fc receptor with human Fc and its mutants by molecular modeling and dynamics simulations.

Authors:  Xiaoqin Huang; Fang Zheng; Chang-Guo Zhan
Journal:  Mol Biosyst       Date:  2013-09-20

3.  Study on the Application of the Combination of TMD Simulation and Umbrella Sampling in PMF Calculation for Molecular Conformational Transitions.

Authors:  Qing Wang; Tuo Xue; Chunnian Song; Yan Wang; Guangju Chen
Journal:  Int J Mol Sci       Date:  2016-05-09       Impact factor: 5.923

4.  Free Energy Landscape of Lipid Interactions with Regulatory Binding Sites on the Transmembrane Domain of the EGF Receptor.

Authors:  George Hedger; David Shorthouse; Heidi Koldsø; Mark S P Sansom
Journal:  J Phys Chem B       Date:  2016-05-09       Impact factor: 2.991

5.  Binding modes of three inhibitors 8CA, F8A and I4A to A-FABP studied based on molecular dynamics simulation.

Authors:  Jianzhong Chen; Jinan Wang; Weiliang Zhu
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.